192 related articles for article (PubMed ID: 35406720)
41. Modification of KL4 Peptide Revealed the Importance of Alpha-Helical Structure for Efficient siRNA Delivery.
Qiu Y; Lo JCK; Kwok KCW; Mason AJ; Lam JKW
Nucleic Acid Ther; 2021 Jun; 31(3):220-228. PubMed ID: 32352853
[TBL] [Abstract][Full Text] [Related]
42. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
Jafari M; Karunaratne DN; Sweeting CM; Chen P
Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
[TBL] [Abstract][Full Text] [Related]
43. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.
Qiu Y; Chow MYT; Liang W; Chung WWY; Mak JCW; Lam JKW
Mol Pharm; 2017 Dec; 14(12):4606-4617. PubMed ID: 29121767
[TBL] [Abstract][Full Text] [Related]
44. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9.
Ziegler A; Seelig J
Biochemistry; 2011 May; 50(21):4650-64. PubMed ID: 21491915
[TBL] [Abstract][Full Text] [Related]
45. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
46. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
47. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
[TBL] [Abstract][Full Text] [Related]
48. Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
Min S; Kim K; Ku S; Park JY; Seo J; Roh S
Biotechnol Prog; 2020 Sep; 36(5):e3014. PubMed ID: 32374475
[TBL] [Abstract][Full Text] [Related]
49. The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides.
Jobin ML; Blanchet M; Henry S; Chaignepain S; Manigand C; Castano S; Lecomte S; Burlina F; Sagan S; Alves ID
Biochim Biophys Acta; 2015 Feb; 1848(2):593-602. PubMed ID: 25445669
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of six-membered carbocyclic ring α,α-disubstituted amino acids and arginine-rich peptides to investigate the effect of ring size on the properties of the peptide.
Kato T; Kita Y; Iwanari K; Asano A; Oba M; Tanaka M; Doi M
Bioorg Med Chem; 2021 May; 38():116111. PubMed ID: 33838611
[TBL] [Abstract][Full Text] [Related]
51. Oligonucleotide delivery with cell surface binding and cell penetrating Peptide amphiphile nanospheres.
Mumcuoglu D; Sardan M; Tekinay T; Guler MO; Tekinay AB
Mol Pharm; 2015 May; 12(5):1584-91. PubMed ID: 25828697
[TBL] [Abstract][Full Text] [Related]
52. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
Gooding M; Browne LP; Quinteiro FM; Selwood DL
Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
[TBL] [Abstract][Full Text] [Related]
53. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9.
Cordier C; Boutimah F; Bourdeloux M; Dupuy F; Met E; Alberti P; Loll F; Chassaing G; Burlina F; Saison-Behmoaras TE
PLoS One; 2014; 9(8):e104999. PubMed ID: 25127364
[TBL] [Abstract][Full Text] [Related]
54. Designing and enhancing the antifungal activity of corneal specific cell penetrating peptide using gelatin hydrogel delivery system.
Amit C; Muralikumar S; Janaki S; Lakshmipathy M; Therese KL; Umashankar V; Padmanabhan P; Narayanan J
Int J Nanomedicine; 2019; 14():605-622. PubMed ID: 30697045
[TBL] [Abstract][Full Text] [Related]
55. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
[TBL] [Abstract][Full Text] [Related]
56. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer.
Yang YY; Zhang W; Liu H; Jiang JJ; Wang WJ; Jia ZY
Drug Des Devel Ther; 2021; 15():4961-4972. PubMed ID: 34916779
[TBL] [Abstract][Full Text] [Related]
57. Enhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligands.
Lin W; Xie X; Yang Y; Liu H; Fu X; Chen Y; Liu H; Yang Y
J Pharm Pharmacol; 2015 Sep; 67(9):1215-31. PubMed ID: 25880614
[TBL] [Abstract][Full Text] [Related]
58. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
[TBL] [Abstract][Full Text] [Related]
59. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
60. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]